WallStreetZenWallStreetZen

NASDAQ: PRVA
Privia Health Group Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PRVA past earnings growth

How has PRVA's earnings growth performed historically?
Company
N/A
Industry
-4.32%
Market
62.15%
PRVA's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PRVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

PRVA past revenue growth

How has PRVA's revenue growth performed historically?
Company
22.19%
Industry
12.03%
Market
17.33%
PRVA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PRVA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PRVA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PRVA earnings and revenue history

Current Revenue
$1.7B
Current Earnings
$23.1M
Current Profit Margin
1.4%

PRVA Return on Equity

Current Company
4.3%
Current Industry
-0.2%
Current Market
188%
PRVA's Return on Equity (4.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PRVA announces earnings.

PRVA Return on Assets

Current Company
2.4%
Current Industry
0.8%
PRVA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRVA Return on Capital Employed

Current Company
3.7%
Current Industry
2.2%
PRVA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRVA vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRVA$1.66B$29.23M$23.08M+20.31%+22.09%
TDOC$2.60B$154.00M-$220.37M+44.16%N/A
PINC$1.32B$368.68M$167.33M+6.01%-23.23%
BTSG$8.83B$351.75M-$154.60M+28.33%N/A
SDGR$216.67M$56.24M$40.72M+26.59%N/A
View Top Health Information Service Stocks

PRVA earnings dates

Next earnings date
May 9, 2024

Privia Health Group Earnings & Revenue FAQ

What were PRVA's earnings last quarter?

On Invalid Date, Privia Health Group (NASDAQ: PRVA) reported Q4 2023 earnings per share (EPS) of $0.03, up 81.25% year over year. Total Privia Health Group earnings for the quarter were $2.84 million. In the same quarter last year, Privia Health Group's earnings per share (EPS) was $0.16.

If you're new to stock investing, here's how to buy Privia Health Group stock.

What was PRVA's earnings growth in the past year?

As of Q2 2024, Privia Health Group's earnings has grown year over year. Privia Health Group's earnings in the past year totalled $23.08 million.

What is PRVA's earnings date?

Privia Health Group's earnings date is Invalid Date. Add PRVA to your watchlist to be reminded of PRVA's next earnings announcement.

What was PRVA's revenue last quarter?

On Invalid Date, Privia Health Group (NASDAQ: PRVA) reported Q4 2023 revenue of $440.83 million up 20.97% year over year. In the same quarter last year, Privia Health Group's revenue was $364.42 million.

What was PRVA's revenue growth in the past year?

As of Q2 2024, Privia Health Group's revenue has grown 22.19% year over year. This is 10.16 percentage points higher than the US Health Information Services industry revenue growth rate of 12.03%. Privia Health Group's revenue in the past year totalled $1.66 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.